Muscle Relaxants Flashcards
Succinylcholine:
Dose, onset, duration
0.6-1.5mg/kg
Less than 1 minute
5 to 10 mins
Succinylcholine phases
- 1 - depolarization with fasciculations
- 2 - repolarization - dose exceeds 2-4mg/kg
Potassium goes up 0.5mEq/L
Succinylcholine metabolism
Pseudocholinesterase
Can be affected by liver disease, anticholinesterases, chemotherapeutic drugs
Atypical plasma cholinesterase can not hydrolyze succinylcholine
Only discovered when more than 1 hour of skeletal muscle paralysis occurs
DMR Side effects
Cardiac dysrhythmias
Hyperkalemia
Myalgia
Myoglobinuria
Increased intraocular, intragastric, intracranial pressure
Trismus
Use atropine to decrease the cardiac effects
NDMR Classification:
Long - d-tubocurarine, metocurine, gallamine, pancuronium, pipecuronium, doxacurium - 3 to 5 - 60 to 90
Intermediate - atracurium, vecuronium, rocuronium
Short - mivacurium
Mivacurium:
6 to 16 min
Plasma cholinesterase
Some histamine release ,- avoid in asthma
Why is pancuronium unique?
Increases HR, BP
Enhance NDMR effect:
VA, aminoglycosides, magnesium, local anesthetics, cardiac antiarrhythmics, calcium blockers
Hypothermia
Reduced pH
Hypokalemia
How to antagonize NMDR?
Anticholiesterases like neostigmine, pyridostigmine
Suggamadex:
Reverses NM blockade
Suggamadex contraindication:
Renal disease
Malignant hyperthermia diagnosis:
Muscle biopsy using the in vitro contracture test:
- femoral nerve block
- remove 8-10 muscle speciments (3-4cm long) from the vastus medialis muscle
- Positive diagnosis if the muscle contracts in response to caffeine or halothane
Signs of malignant hyperthermia:
- Sustained jaw rigidity
- Unexplained tachycardia w/ an unexpected rise in ETCO2 or minute volume
- Falling SaO2 despite increased FiO2
- CVS instability
- Generalized rigidity
- Core temperature rise of 2C per hour
How to manage a patient with a history of malignant hyperthermia?
- Avoid succinylcholine and volatile anesthetics
- Baseline core temperature and measuring of core temperature
- Dantrolene should be handy
One of the more serious effects of succinylcholine is ___________
This effect can be reduced by administration with _______
Cardiac dysrhythmias
Atropine
Effects of succinylcholine
Cardiac dyr
INhythmias
Hyperkalemia
Myoglobinuria
Increased intraocular pressure
Increased intragastric pressure
Increased intracranial pressure
Trismus (especially in pediatrics)
Pharmacokinetics of NDMR’s:
- Highly ionized and possess limited lipid solubility
- Can not easily pass lipid membranes
- Do not produce CNS effects
- Renal tubular reabsorption is minimum
- Oral administration is not effective
- Maternal administration does not affect the fetus
Long-acting NDMR doses:
D-Tubocurarine - 0.51 mg/kg
Metocurine - 0.28mg/kg
Gallamine 1.0mg/kg
Pancuronium - 0.07mg/kg
Pipecuronium - 0.07mg/kg
Doxacurium - 0.25-0.40mg/kg
Intermediate-acting NMDR doses:
Atracurium - 0.3-0.6mg/kg
Cisatracurium - 150ug/kg
Vecuronium 80-100ug/kg
Rocuronium - 0.6-1.0mg/kg
Mivacurium dose, kinetics
Intubation - 0.07-0.25mg/kg
Infusion- 0.4-0.6mg/kg/h
6-16mins
Some histamine release, avoid in asthma
Factors enhancing NDMR effects:
- Drugs - VA’s, AG AB’s, Mg, local anesthetics, antiarrhythmics, CCB’s
- Hypothermia
- Reduced pH
- Hypokalemia
Test to determine fi there is no significant NM block:
- Head lift
Anticholinesterases like _______ can cause _____ this can be prevented with use of _________
neostigmine
pyridostigmine
bradycardia
atropine
Suggamadex use and contraindication
Reversal of NM blockade by NDMR
Do not use with renal disease
In vitro contracture test:
Performed under ______
8-10 segments about 3-4cm long are removed from the __________
Diagnosis is considred positive if the muscle contracts in response to________
Femoral nerve block
Vastus medialis muscle
Caffeine or halothane
Signs of MH:
- Muscle rigidity
- Jaw rigidity
- Unexpected tachycardia w/ unexpected rise in ETCO2
- Falling SaO2 but increase in FiO2
- Cardiovascular instability
- Generalized rigidity
- Core temperature rises 2C per hour
A patient is experiencing symptoms of MH during surgery, what do we do?
Stop giving the causative medication
Give 100% oxygen
Give dantrolene 1mg/kg - usually require 2.4mg/kg, up to 10mg/kg can be used
Reduce core temperature with cold fluid IV
Correct acidosis and hyperkalemia